نحوه مصرف
توصیه های دارویی مامیران
منابع
1- Maji AK, Banerji P. Chelidonium majus L. (Greater celandine)-A Review on its Phytochemical and Therapeutic Perspectives.International Journal of Herbal Medicine. 2015;3 (1):10-27.
2- Ernst E, Schmidt K. Ukrain-a new cancer cure? A systematic review of randomized clinical trials. BMC cancer. 2005; 5(1):1-7.
3- Ghorbanli M, Fani P, Sateei A. Seasonal changes of alkaloids and phenolic compounds in Chelidonium Majus L. in two habitats. Journal of Plant Environmental Physiology 2009; 3, 4(15); 65-74.
4- Gilca M, Gaman L, Panait E, Stoian I, Atanasiu V. Chelidonium majus - An integrative review: Traditional knowledge versus modern findings. Forsch Komplementmed 2010; 17(5): 241-8.
5- Zare Shahneh F, Baradaran B, Orangi M, Zamani F. In vitro cytotoxic activity of four plants used in persian traditional medicine. Adv Pharm Bull 2013; 3(2): 453-5.
6-Biswas SJ. Chelidonium majus L. Areviewon Pharmacological activities and clinical effects. Global. J. Res, Med. Plants & indigen, Med. 2013;2 (41): 238 - 45.
7-Benninger J, Schneider H. T, Schuppan D, Kirchner T and Hahn E.G.(1999). Acute hepatitis induced by greater celandine (Chelidoniummajus).Gastroenterology117: 1234-1237.
8-Williams R. J, Spenser J. P. E and Rice Evans C. (2004). Flavonoids: 16-antioxidants or signalling molecules, Free Radic Biology Mededicinal.36: 838-49.
9-Moro PA, Cassetti F, Giugliano G, Falce MT,Mazzanti G, Menniti-IPPolito F and et al. HePatitis from Greater celandine (Chelidonium majus L.):review of literature and rePort of a new case. J. EthnoPharmacol. 2009 15; 124 (2): 328 - 32.
10- Brand N. Foeniculum. In: Hansel R, Keller K,RimPler H. Schneider G, editors.Hagers Handbuch der Pharmazeutischen Praxis, 5th ed. Volume 5:Drogen E-O. Berlin-Heidelberg-New York- London: SPringer-Verlag.: 1993, PP: 156 - 81.
11- Ulrichova J, Walterova D, Vavreckova C,Kamarad V and Simanek V. Cytotoxicity of Benzo[c] Phenanthridinium Alkaloids in Isolated Rat HePatocytes. Phytotherapy Res. 1996; 10 (3): 220- 3.
12- ضیایی، علی،مسگرپور، بیتا (1384). احتیاط مصرف و تداخلات دارویی گیاهان دارویی بر اساس شواهد و مستندات،انتشارات تیمورزاده- نشر طبیب.
13- Kowalczyk D, Swieca M, Cichocka J,Gawlik-Dziki U. The phenolic content and antioxidant activity of the aqueous and hydroalcoholic extracts of hops and their pellets. Journal of the Institute of Brewing. 2013; 119(3):103-10.
14- Singh LR, Singh OM. Datura stramonium:An overview of its phytochemistry and pharmacognosy. Research Journal of Pharmacognosy and Phytochemistry. 2013;5(3): 143-8.
15-Fernández SP, Wasowski C, Loscalzo LM,Granger RE, Johnston GA, Paladini AC, et al.Central nervous system depressant action of flavonoid glycosides. European journal of pharmacology. 2006; 539(3):168-76.
16- Gupta R, Singh M, Sharma A.Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury. Pharmacological Research. 2003; 48(2):209-15.
17-Koneri RB, Samaddar S, Simi S, Rao ST.Neuroprotective effect of a triterpenoid saponin isolated from Momordica cymbalaria Fenzl in diabetic peripheral neuropathy. Indian journal of pharmacology. 2014; 46(1):76-7.
18-Monavari H, Hamkar R, Norooz-Babaei Z, Adibi L, Noroozi M, Ziaei A. Antiviral effect assay of twenty five species of various medicinal plants families in Iran. Iran J Med Microbiol 2007; 1(2):49-59.
19-Biswas SJ. Chelidonium majus L. Areviewon Pharmacological activities and clinical effects.Global. J. Res, Med. Plants & indigen, Med. 2013;2 (41): 238 - 45.
20-Xia X, Yan J, Shen Y, Tang K, Yin J, Zhang Y,Yang D, Liang H, Ye J and Weng J. Berbrin imProves glucose metabolism in diabetic rats by inhibition of hePatic gluconeogenesis. PLOS One.2011; 3 6 (2): el6556.
21-Mazzanti G, Sotto A Di, Franchitto A, Mammola CL, Mariani P, Mastranglos and Menniti-IPPolito F. Vitalone AChelidonium majus is not hePatotoxic in wistar rats, in a 4 weeks feeding exPeriment. J. EthnoPharmacol. 2009; 126 (3): 518 - 24.
